Genpact Limited (NYSE:G) Short Interest Update

Genpact Limited (NYSE:GGet Free Report) was the recipient of a large decrease in short interest in December. As of December 31st, there was short interest totalling 5,090,000 shares, a decrease of 7.6% from the December 15th total of 5,510,000 shares. Based on an average daily trading volume, of 1,310,000 shares, the days-to-cover ratio is presently 3.9 days. Approximately 3.2% of the shares of the stock are sold short.

Wall Street Analyst Weigh In

A number of research firms have recently commented on G. TD Cowen upped their target price on Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a research note on Friday, November 8th. Needham & Company LLC upped their price objective on Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, November 11th. Finally, Robert W. Baird increased their target price on Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Eight research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $42.33.

View Our Latest Report on Genpact

Insider Activity

In related news, CEO Balkrishan Kalra sold 9,000 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $46.40, for a total value of $417,600.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at $12,407,545.60. This trade represents a 3.26 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the business’s stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 35,058 shares of company stock worth $1,558,675. 2.80% of the stock is currently owned by corporate insiders.

Institutional Trading of Genpact

Institutional investors and hedge funds have recently made changes to their positions in the company. Jensen Investment Management Inc. lifted its position in Genpact by 6.4% during the third quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider’s stock valued at $7,449,000 after acquiring an additional 11,410 shares during the last quarter. Stifel Financial Corp acquired a new position in shares of Genpact during the third quarter worth $1,197,000. Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Genpact by 53.1% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 49,134 shares of the business services provider’s stock valued at $1,580,000 after purchasing an additional 17,034 shares during the last quarter. Burney Co. boosted its position in shares of Genpact by 242.8% in the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider’s stock worth $5,618,000 after purchasing an additional 92,641 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in Genpact by 192.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock worth $122,701,000 after buying an additional 2,060,595 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors.

Genpact Stock Up 0.7 %

NYSE G traded up $0.29 on Friday, reaching $45.13. 956,882 shares of the stock traded hands, compared to its average volume of 1,135,612. Genpact has a 12 month low of $30.23 and a 12 month high of $47.98. The company has a market cap of $7.96 billion, a price-to-earnings ratio of 12.40, a PEG ratio of 1.43 and a beta of 1.18. The company has a fifty day moving average price of $44.44 and a 200-day moving average price of $39.78. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85.

About Genpact

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Recommended Stories

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.